Plate osteosynthesis versus hemiarthroplasty in proximal humerus fractures – Does routine screening of systemic inflammatory biomarkers makes sense? by Horst, Klemens et al.
EUROPEAN JOURNAL 
OF MEDICAL RESEARCH
Horst et al. European Journal of Medical Research  (2015) 20:5 
DOI 10.1186/s40001-014-0079-zRESEARCH Open AccessPlate osteosynthesis versus hemiarthroplasty in
proximal humerus fractures – Does routine
screening of systemic inflammatory biomarkers
makes sense?
Klemens Horst*, Frank Hildebrand, Roman Pfeifer, Karin Köppen, Philipp Lichte, Hans-Christoph Pape
and Thomas DienstknechtAbstract
Background: Increases in C-reactive protein (CRP) and white blood cell (WBC) counts after orthopedic surgical
procedures can give evidence of postoperative infection. However, there is a lack of knowledge about the kinetics
of these biomarkers in cases with an uneventful clinical course after osteosynthesis of upper limb fractures. This
study investigated CRP and WBC serum levels after osteosynthesis or hemiarthroplasty of humeral head fractures.
Methods: A retrospective study on patients with humeral head fractures who had open reduction and internal fixation
via plate osteosynthesis (PO) (n = 64) or hemiarthroplasty (HA) (n = 28) without any complications in the postoperative
clinical course. C-reactive protein serum levels (mg/l) and leukocyte counts (g/l) were assayed at several time points.
Multiple regression analysis was performed to evaluate the influence of several confounding variables (the surgical
procedure, duration of surgery, patient’s health status, and comorbidities) on the kinetics of CRP and WBC.
Results: Our data showed that CRP levels were statistically significantly higher in the HA cohort when compared to the
PO cohort (p = 0.003). Moreover, daily measurement of CRP levels during the postoperative course showed that CRP
peaked on the 2nd and 3rd days postoperatively in both cohorts and started to decrease afterward, reaching normal
values on day 8 to 10. However, WBCs did not show any significant differences between the HA and PO cohorts.
Finally, the choice of surgical procedure and the patient’s health status were associated with higher peak levels of CRP.
Conclusions: After osteosynthesis or hemiarthroplasty of humeral head fractures, CRP is a responsive serum parameter
in the postoperative course of an uneventful inflammatory response. Abnormalities from these values should be
interpreted carefully as they may give a hint as to postoperative complications such as infection.
Keywords: CRP, Infection, Perioperative monitoring, Plate fixation, Proximal humerus fracture, Shoulder
arthroplasty, WBCBackground
The incidence of humeral head fractures is increasing
rapidly [1,2], especially in the elderly female population
[2]. Several factors associated with humerus fractures
have been identified: fragile bones and a patient at specific
risk of falls. Operative treatment is frequently necessary
but complication rates are high and increase with the
degree of fracture severity [3-6]. Typical complications* Correspondence: khorst@ukaachen.de
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unless otherwise stated.vary from malreduction to loss of anatomic fracture
fixation, screw perforation, rotator cuff failure, infections,
and delayed healing [7,8]. After surgical treatment of
humeral head fractures, several complications have
been identified either from the surgical technique
(malreduction, perforating screws) or during the clinical
course, especially postoperative infections [9,10].
C-reactive protein (CRP), an acute-phase protein, is
known as a useful biomarker in detecting infections
postoperatively [11-13]. Furthermore, the kinetics of
systemic CRP levels have been associated with thehis is an Open Access article distributed under the terms of the Creative
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uneventful postoperative courses show a temporary
increase in CRP levels [18-21]. For these reasons, the
postoperative kinetics of systemic CRP concentrations
need further investigation to differentiate between elevation
related to a surgical procedure and elevation associated
with infection in the postoperative course. Previous studies
have investigated changes in CRP levels after diverse
orthopedic procedures [22-24] as well as the leukocyte
kinetics [25,26]. However, the kinetics of systemic CRP
and WBC depend on both the severity and type of surgical
procedure (e.g., tissue damage) as well as patient-related
circumstances (e.g., health status, comorbidities) [22-24].
Therefore, investigating these effects in relation to specific
anatomical regions and different operative procedures is
important.
In the current study, we aimed to assess the kinetics of
routine laboratory markers (CRP, WBC) after different
surgical treatments of humeral head fractures. Additionally,
we assessed the degree to which postoperative CRP/WBC
kinetics are influenced by the patient’s comorbidities and
perioperative status.
Methods
Patient enrolment
This retrospective study ran from 1 January 2010 to 31
December 2012, during which time 125 patients needed
surgical treatment for proximal humerus fractures at
Aachen University Medical Centre. Patients eligible for
enrollment in the study presented with isolated humeral
head fracture and were treated operatively using either
plate osteosynthesis (PO) or hemiarthroplasty (HA). As no
evidence-based recommendations on the treatment of prox-
imal humerus fracture can be derived from the currently
available data, the decision for either PO or HA was made
in regard to the patients individual characteristics (biological
age and bone quality, accompanying illnesses, compliance)
and needs as recommended by Burkhart et al. and others
[27-29]. Reasons for ineligibility were staged procedures or a
history of autoimmune or inflammatory disorders, liver dis-
ease (including hepatitis), cancer, infectious complications
after surgery, or postoperative antibiotic use.
Clinical data
Laboratory results and other demographic data: comorbidi-
ties (diabetes mellitus, nicotine use, and alcohol misuse),
ASA score, duration of the surgical procedure (from skin
incision to closure), use of perioperative antibiotics, and the
total length of stay in the hospital were collected from each
patient’s chart.
Analysis of inflammation biomarkers
Plasma levels of CRP and WBC were documented before
surgery (at the time of admission) and on days 2 to 3, 4 to5, 6 to 7, and 8 to 10 after the surgical procedure. Serum
CRP was quantified by the Cobas 8000 modular analyzer
series (Roche), while WBC was obtained using TS-2000
(Sysmex). CRP was reported in mg/l and WBC in g/l.
Surgery
All surgical procedures were performed under general
anesthesia. Perioperative antibiotic medication was cefur-
oxim 1.5 g (single shot) or clindamycin 1.5 g in cases of
known allergic reaction to cefuroxim. A deltopectoral
approach was used. Sutures were set into the insertions
of the subscapularis, supraspinatus, and infraspinatus
tendon. The humeral head was exposed to optimize
visualization during the reduction procedure. Reduction
was performed using digital pressure and retractors.
Reduction of the tuberositas was performed. The result
was held by temporary k-wires. The plate was attached to
the humeral shaft with a bicortical screw inserted through
the elongated hole. The plate position was checked by
fluoroscopy and optimized before the rest of the screws
had been inserted. Angular stable as well as normal plates
were used. Finally, the rotator cuff tendons were secured
via the sutures that were brought through the small holes
in the plate.
Performing hemiarthroplasty, tendon sutures were set
as described above. The humeral head was exposed by
dividing the soft tissues over the fracture. The remaining
medial capsular attachment to the head was released,
and all fragments were removed. The humeral head was
kept for later size measurements. The glenoid fossa was
inspected, and the tuberositas were prepared. The
medullary canal was opened and enlarged with rasps of
increasing sizes. Humeral retroversion was measured
and humeral head size determined. In the following step,
the prosthesis was inserted (EPOCA, Synthes), the joint
was reduced, and the tuberositas were fixated. Wound
closure and final radiographic visualization as well as range
of motion were verified at the end of the procedures.
Statistical analysis
The statistical analysis was performed using the Statistical
Package for Social Sciences (SPSS) (version 21.0.0.0).
Variables such as age, body weight, BMI, duration of
surgery, hospital length of stay, and peak values of
CRP and WBC are reported as the mean and standard
deviation (SD). The Kolmogorov-Smirnov test was
performed to test for normal distribution. Student’s t-test
and paired t-tests were used when applicable. The
Mann–Whitney U-test was used if values were not
normally distributed. Categorical variables are presented
as frequencies (relative), and heterogeneities between the
groups were assessed by chi-square tests. To assess
the effect of the treatment modality on the peak values of
the inflammatory parameters with adjustment for potential
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sion models. P < 0.05 was considered statistically significant
for all analyses.Results
Demographics and clinical outcomes of cohorts
The overall study cohort consisted of 125 patients
who were admitted to our hospital for humeral fracture
fixation. Of these patients, 92 met our selection criteria
(see Methods). Sixty-four patients had plate osteosynthesis
(PO), and 28 had hemiarthroplasty (HA). Interestingly, our
data showed that the HA cohort had a statistically
significantly higher BMI (P = 0.013), longer operation time
(P = 0.001), and longer hospital length of stay (P = 0.001)
compared to the PO cohort. There was no statistical
difference in age between the groups, but a trend toward
an older population in the HA cohort (P = 0.051)
(Table 1).Kinetics of CRP
We measured CRP in a continuous fashion, preoperatively
(time of admission), and then from day 1 up to 10 days
postoperatively. Our data showed that preoperative
values of CRP were increased in both groups (Table 2).
Interestingly, the HA and PO groups had significant
increases in CRP during the postoperative phase whenTable 1 General patient characteristics, comorbidities, and AS
Society of Anaesthesiologists classification)
Plate osteosynthesis
(n = 64)
General characteristics
Age 64 ± 17
Gender (female) 46 (73%)
Body weight (kg) 73 ± 16
BMI 26 ± 5
BMI >25 30 (47%)
Duration of Surgery (min) 111 ± 50
Duration of Surgery >2 h (n) 24 (37.5%)
Hospital length of stay (days) 7 ± 4
Comorbidities
Nicotine 6 (9%)
Alcohol 4 (6%)
Diabetes mellitus 11 (17%)
ASA
I 3 (5%)
II 42 (66%)
III 20 (31%)
IV 0 (0%)
V 0 (0%)compared to baseline (HA, p = 0.001; PO, p = 0.001)
(Figures 1 and 2). Moreover, the highest CRP levels
were observed between the 2nd and 3rd postoperative
days in both groups. Indeed, there was a statistically
significant difference in the peak values between the
HA and PO groups (p = 0.010), where HA had higher
levels of CRP. Finally, our analysis showed that there
was a continuous decrease in CRP values over time
till the baseline levels were reached between the 8th
and 10th postoperative days (Table 2, Figure 1).Kinetics of WBC
We measured WBC counts in the same fashion as CRP.
Our analysis showed no statistical difference in WBC
counts in the preoperative phase when compared to the
baseline. In addition, there was no statistical difference
in WBC counts between the HA and PO groups over
time in the postoperative course. Finally, we observed a
continuous decrease in WBC counts after the surgical
intervention, with the lowest counts at the end of the
observation time (p = 0.051) (Table 2, Figure 2).Influence of the surgical procedure and patient’s health
status
Multiple regression analysis was carried out to assess
correlations between CRP and WBC peak values and theA-classification, * = p <0.05 (ASA-classification: American
Hemiarthroplasty p-value
(n = 28)
71 ± 12 0.051
18 (64%) 0.459
82 ± 21 0.026*
29 ± 7 0.013*
17 (61%) 0.208
150 ± 57 0.001*
20 (71%) 0.003*
11 ± 6 0.001*
1 (4%) 0.337
0 (0%) 0.179
5 (18%) 0.938
1 (4%) 0.810
14 (50%) 0.160
12 (43%) 0.285
1 (4%) 0.131
0 (0%) N/A
Table 2 Mean profiles of CRP and WBC values pre- and
postoperatively, * = p <0.05
Plate osteosynthesis Hemiarthroplasty p-value
(n = 64) (n = 28)
CRP (mg/L)
Preoperatively 20 ± 27 27 ± 35 0.387
Day 1 55 ± 37 99 ± 54 0.003*
Day 2-3 76 ± 61 132 ± 57 0.003*
Day 4-5 55 ± 53 82 ± 42 0.013*
Day 6-7 41 ± 23 63 ± 44 0.119
Day 8-10 30 ± 25 47 ± 41 0.513
WBC (G/L)
Preoperatively 10.0 ± 3.4 10.4 ± 3.2 0.248
Day 1 9.9 ± 3.4 10.5 ± 2.8 0.319
Day 2-3 8.5 ± 3.0 10.0 ± 3.0 0.137
Day 4-5 7.5 ± 2.2 8.3 ± 2.0 0.113
Day 6-7 7.4 ± 2.5 8.3 ± 2.0 0.423
Day 8-10 6.5 ± 2.8 7.8 ± 1.8 0.438
Figure 2 Kinetics of postoperative WBC levels: plate
osteosynthesis (PO) vs. hemiarthroplasty (HA).
Table 3 Multiple regression analysis of peak CRP and
WBC values, * = p <0.05
Peak CRP Peak WBC
PO vs. HA PO vs. HA
Model Summary
Adjusted R2 0.22 0.07
ANOVA
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approach used and duration of surgery) as well as the
general health status (American Society of Anesthesiologists
risk classification (ASA) and body mass index (BMI)]
of the patients. In this context, the ASA classification
and surgical approach were significantly correlated
with peak CRP levels (Table 3). However, there was
no significant correlation with the duration of the
surgical intervention and BMI (Table 3). On the
other hand, postoperative WBC peaks did not show
any correlation with the parameters we assessed
(Table 3). Furthermore, we tested whether preopera-
tive parameters such as age and ASA might predict
the choice of surgical approach but did not find a
significant correlation.Figure 1 Kinetics of postoperative CRP levels after plate
osteosynthesis (PO) vs. hemiarthroplasty (HA), *p < 0.05 on days
1, 2–3 and 4–5.Comorbidities
The prevalences of comorbidities between the HA and
PO cohorts were comparable (Table 1). Multiple regression
analysis showed that CRP and WBC peaks were not corre-
lated with any comorbidities we observed in our patients.
Discussion
Humeral head fracture is common in all age groups
[1,30,31], particularly in aged patients. In addition, being
female increases the odds [1,2,30]. Falls and motor
vehicle accidents (MVA) can cause humeral fractures
[31]. However, while different surgical approaches can
be used in treating such fractures, controversy still
remains over which should be chosen: plate osteosynthesis
(PO), hemiarthroplasty (HA), or total arthroplasty (TSA).F-value 7.2 2.6
p-value <0.001* 0.041*
Coefficients
Constant (SE) −75.35 (35.11) 8.43 (2.11)
p-value 0.035* <0.001*
ASA 29.15 (10.36) −0.85 (0.62)
p-value 0.006* >0.05
Surgical procedure 40.15 (14.32) 0.97 (0.86)
p-value 0.006* >0.05
Surgical duration 0.072 (0.12) 0.01 (0.01)
p-value >0.05 >0.05
BMI 1.36 (1.04) 0.07 (0.06)
p-value >0.05 >0.05
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both the patient’s health status and the severity of the
fracture, along with the surgeon’s experience [29].
Moreover, technical problems (screw perforation and
malreduction) and postoperative complications (infection)
in the clinical course can affect the outcome. Surgical
intervention affects the inflammatory response, especially
in the early phase [32]. Certain complications may occur
during this critical phase, of which wound infections are
of high importance. However, lack of knowledge about the
proper postoperative inflammatory response after surgical
intervention for humeral head fractures can lead to over-
looked complications or misdiagnosis [7,10]. In this con-
text, CRP is an acute phase protein that can be used as a
marker for changes in the orthopedic postoperative inflam-
matory response. Yet, it is a necessary prerequisite to know
the kinetics of CRP in the case of an uneventful postopera-
tive course [32]. Our analysis showed that CRP peaks on
the 2nd to 3rd day after the PO or HA procedure. More-
over, both surgical approaches affect CRP values regardless
of the duration of the surgery as well as the patient’s health
status. However, our analysis did not show any comorbidi-
ties in our patients that affected CRP values.CRP kinetics in orthopedic trauma
The increase in preoperative CRP values in our data can
be explained by the well-known early elevation of
systemic CRP levels after tissue damage [33,34]. The
postoperative course is affected by age, the type of surgical
approach, and operated body region [22-24,32,35-37]. In
the field of orthopedic trauma, several studies have
examined the effect of different surgical approaches
to hip fracture [23,38,39]. Neumaier et al. studied the
CRP kinetics after surgery in different body regions.
However, regarding the postoperative CRP kinetics of
the humerus, the author did not distinguish between
surgery of the proximal humerus, the shaft or the distal
part of the humerus. Also no difference was reported in
diverse surgical procedures regarding humerus fractures
[32]. Moreover, they did not find an effect of the particular
surgical approach on peak CRP levels. In this context, our
analysis showed that CRP levels rise to their maximum
amplitude on the 2nd to 3rd postoperative day with both
the HA and PO approaches. Furthermore, peak levels in
HA patients were significantly higher than those in
patients with the PO approach, but showed an equivalent
decrease after reaching their peak. These patterns were
comparable to previously published reports comparing
osteosynthesis versus arthroplasty and reflect the patient’s
recovery [22,23]. In contrast to this course of CRP after
uneventful orthopedic surgery, a secondary increase
or a persistent elevation in cases where infectious
complications develop has been described [22].Influence of surgical approach on CRP kinetics
The severity of the tissue damage, type of tissue (fat,
muscle, or bone), and traumatized body region have
all been shown to influence postoperative CRP kinetics
[22,23,40,41]. Most previous studies have focused on CRP
kinetics after operative treatment of lower limbs (femur
and knee) or the vertebral column after trauma [22,24,41].
However, our study revealed CRP kinetics after uneventful
operative treatment of humeral head fractures by comparing
two different approaches to surgical treatment. Our results
suggest that the HA approach is associated with higher CRP
peaks when compared to the PO approach.
In conclusion, our findings support the proposition
that high CRP concentrations correlate positively with
increased damage to muscles and bone caused by
removing the humeral head, using a reamer to pre-
pare the intramedullary canal and cementing the
prosthesis [41,42].
Comorbidities and CRP kinetics
The literature regarding several affecting factors (type
of operation, patient health status, and demographic-
related factors) is contradictory [43]. Larsson et al. reported
that the type of anesthesia, amount of bleeding, transfusion,
operation time, administered drugs (antibiotics), age, and
gender did not have any influence on peak CRP levels. On
the other hand, other studies showed that the duration of
surgery, obesity, and the use of anesthetics influence
postoperative immunologic reactions [24,38,44]. In
contrast to Kraft et al., our data show that a patient’s
health status as measured by the ASA classification is
positively correlated with CRP peaks [24], because the
population investigated by Kraft et al. experienced different
surgical interventions and was younger than ours. In this
context, as age is known to be associated with a significant
reduction in a patient’s overall health status, we conclude
that a reduced ASA classification may contribute to higher
CRP peaks postoperatively. This observation could not be
proven for single comorbidities such as obesity, alcohol or
nicotine abuse, and diabetes mellitus, strengthening the
proposition to consider the patient’s overall health
status rather than single comorbidities when evaluating
postoperative CRP.
Leukocyte kinetics
In accordance with previously published studies, we
observed a postoperative decrease in WBC counts
[24,45]. Moreover, there was no significant difference
in the WBC counts or in their peak levels between
the HA and PO cohorts. This difference in the kinetics of
WBC and CRP is explainable, as CRP shows an individual
stability and narrow normal range, is barely influenced by
common comorbidities (except liver diseases), and shows
distinctive patterns with different surgical approaches. In
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WBC in detecting any unusual changes in the early
postoperative phase [24,46].
Limitations
We recognize that there are several limitations in
our study. First, this study was a retrospective study
performed at a single trauma center, and thus it may
not be generalizable or pertinent to other centers
with differing admission demographics, injury characteris-
tics, or management practices. Also, it would have been
interesting to gain information about the kinetics of
advanced inflammatory parameters (e.g., IL-6). Moreover,
we had limited patient numbers. In general, younger
patients and non-displaced or mildly displaced fractures
are treated conservatively, while the treatment of choice
for displaced proximal humerus fractures is anatomical
reconstruction and osteosynthesis. In the elderly, the
implantation of a prosthesis may need to be considered in
order to restore painless, robust function of the humerus,
and thus personal independence, as rapidly as possible.
Information about individual aspects that led to the
decision to employ HA or PO was lacking. However,
studies regarding threshed values for either one surgical
technique are sparse and should gain more attention as
guidelines are necessary. Finally, our study was restricted
to a specific injury and operative approaches, and detailed
information about wound length as another indicator for
surgical trauma was not documented (HA vs. PO).
Conclusions
In conclusion, the current study demonstrates unique
inflammatory biomarker patterns, particularly in the
early events post-injury, which emerge in humeral head
fracture patients, suggesting that CRP can potentially
predict or help in diagnosing postoperative complications.
In the context of the presented data and literature we
suggest routine measurement of serum CRP levels in
a continuous fashion from the day of admission, 2nd
to 3rd, and 4th to 5th day postoperatively, as secondary
relapse may help in detecting postoperative infection
[22,32]. If so, screening for the source of infection
(e.g., wound infection, pneumonia, urinary tract infection)
should start immediately. Finally, further studies are
needed to validate the sufficiency of the time intervals we
suggest for early detection of infectious complications after
proximal humerus fracture fixation.
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